GPR3 Stimulates Aβ Production via Interactions with APP and β-Arrestin2

The orphan G protein-coupled receptor (GPCR) GPR3 enhances the processing of Amyloid Precursor Protein (APP) to the neurotoxic beta-amyloid (Aβ) peptide via incompletely understood mechanisms. Through overexpression and shRNA knockdown experiments in HEK293 cells, we show that β-arrestin2 (βarr2), a GPCR-interacting scaffold protein reported to bind γ-secretase, is an essential factor for GPR3-stimulated Aβ production. For a panel of GPR3 receptor mutants, the degree of stimulation of Aβ production correlates with receptor-β-arrestin binding and receptor trafficking to endocytic vesicles. However, GPR3’s recruitment of βarr2 cannot be the sole explanation, because interaction with βarr2 is common to most GPCRs, whereas GPR3 is relatively unique among GPCRs in enhancing Aβ production. In addition to β-arrestin, APP is present in a complex with GPR3 and stimulation of Aβ production by GPR3 mutants correlates with their level of APP binding. Importantly, among a broader selection of GPCRs, only GPR3 and prostaglandin E receptor 2 subtype EP2 (PTGER2; another GPCR that increases Aβ production) interact with APP, and PTGER2 does so in an agonist-stimulated manner. These data indicate that a subset of GPCRs, including GPR3 and PTGER2, can associate with APP when internalized via βarr2, and thereby promote the cleavage of APP to generate Aβ.

[1]  Roger M. Nitsch,et al.  Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion (*) , 1996, The Journal of Biological Chemistry.

[2]  M. Caron,et al.  G-protein-coupled receptors: regulatory role of receptor kinases and arrestin proteins. , 1992, Cold Spring Harbor symposia on quantitative biology.

[3]  Robert J. Lefkowitz,et al.  Transduction of Receptor Signals by ß-Arrestins , 2005, Science.

[4]  J. Shine,et al.  Isolation and chromosomal localization of a novel human G-protein-coupled receptor (GPR3) expressed predominantly in the central nervous system. , 1994, Genomics.

[5]  A. Scheer,et al.  Mutational analysis of the highly conserved arginine within the Glu/Asp-Arg-Tyr motif of the alpha(1b)-adrenergic receptor: effects on receptor isomerization and activation. , 2000, Molecular pharmacology.

[6]  J. Benovic,et al.  Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. , 1996, Nature.

[7]  D. Selkoe,et al.  The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway , 1995, Nature Medicine.

[8]  S. Karnik,et al.  Modulation of GDP Release from Transducin by the Conserved Glu134-Arg135 Sequence in Rhodopsin* , 1996, The Journal of Biological Chemistry.

[9]  Yun Bai,et al.  Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. , 2006, Nature medicine.

[10]  Sebastian Munck,et al.  β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease , 2013, Nature Medicine.

[11]  Robert J. Lefkowitz,et al.  beta-arrestins: traffic cops of cell signaling. , 2004, Current opinion in cell biology.

[12]  B. De Strooper,et al.  The Orphan G Protein–Coupled Receptor 3 Modulates Amyloid-Beta Peptide Generation in Neurons , 2009, Science.

[13]  B. Winblad,et al.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid , 1992, Nature Genetics.

[14]  R. Lefkowitz,et al.  Trafficking Patterns of β-Arrestin and G Protein-coupled Receptors Determined by the Kinetics of β-Arrestin Deubiquitination* , 2003, The Journal of Biological Chemistry.

[15]  T. S. Kobilka,et al.  Enhancement of membrane insertion and function in a type IIIb membrane protein following introduction of a cleavable signal peptide. , 1992, The Journal of biological chemistry.

[16]  G Vassart,et al.  Molecular cloning of an orphan G-protein-coupled receptor that constitutively activates adenylate cyclase. , 1995, The Biochemical journal.

[17]  J. Benovic,et al.  β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor , 1996, Nature.

[18]  L. Hunyady,et al.  Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Selkoe,et al.  Generation of amyloid β protein from its precursor is sequence specific , 1995, Neuron.

[20]  M. Caron,et al.  The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Ole A. Andreassen,et al.  A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline , 2012, Nature.

[22]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[23]  R. Lefkowitz,et al.  beta-arrestins: traffic cops of cell signaling. , 2004, Current opinion in cell biology.

[24]  A. Scheer,et al.  Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. , 2001, The Journal of biological chemistry.

[25]  L. Hunyady,et al.  Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Gainetdinov,et al.  Physiological roles of G protein-coupled receptor kinases and arrestins. , 2007, Annual review of physiology.

[27]  Bill Wilson,et al.  Intensity of dementia through latent variable modelling (I-DeLV) in the AIBL cohort , 2012, Alzheimer's & Dementia.

[28]  D. Selkoe,et al.  Resolving controversies on the path to Alzheimer's therapeutics , 2011, Nature Medicine.

[29]  Jie Zhang,et al.  The β2-adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis , 1999 .

[30]  M. Conti,et al.  The G-protein-coupled receptors GPR3 and GPR12 are involved in cAMP signaling and maintenance of meiotic arrest in rodent oocytes. , 2005, Developmental biology.

[31]  R. Lefkowitz,et al.  Desensitization of G protein-coupled receptors. , 1996, Recent progress in hormone research.

[32]  R. Wurtman,et al.  Prostaglandin E2 regulates amyloid precursor protein expression via the EP2 receptor in cultured rat microglia , 2004, Neuroscience Letters.

[33]  Marc Cruts,et al.  Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases , 2012, Human mutation.

[34]  K Konvicka,et al.  Interactive construction of residue-based diagrams of proteins: the RbDe web service. , 2000, Protein engineering.

[35]  Todd E. Golde,et al.  Targeting Aβ and tau in Alzheimer's disease, an early interim report , 2010, Experimental Neurology.

[36]  Gang Pei,et al.  A GPCR/secretase complex regulates β- and γ-secretase specificity for Aβ production and contributes to AD pathogenesis , 2010, Cell Research.

[37]  R. Lefkowitz,et al.  Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination. , 2003, The Journal of biological chemistry.

[38]  M. Boutros,et al.  Loss of PAFAH1B2 Reduces Amyloid-β Generation by Promoting the Degradation of Amyloid Precursor Protein C-Terminal Fragments , 2012, The Journal of Neuroscience.

[39]  M. Caron,et al.  Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.

[40]  R. Lefkowitz,et al.  Beta-arrestins and cell signaling. , 2007, Annual review of physiology.

[41]  M. Sheng,et al.  Activity-Induced Polo-Like Kinase 2 Is Required for Homeostatic Plasticity of Hippocampal Neurons during Epileptiform Activity , 2008, The Journal of Neuroscience.

[42]  A. Evsikov,et al.  The Gs-Linked Receptor GPR3 Maintains Meiotic Arrest in Mammalian Oocytes , 2004, Science.

[43]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[44]  R. Lefkowitz,et al.  Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Selkoe,et al.  Generation of amyloid beta protein from its precursor is sequence specific. , 1995, Neuron.

[46]  Yun Bai,et al.  Activation of β2-adrenergic receptor stimulates γ-secretase activity and accelerates amyloid plaque formation , 2006, Nature Medicine.

[47]  M. Kivipelto,et al.  Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention , 2009, Dialogues in clinical neuroscience.

[48]  R. Lefkowitz,et al.  β-Arrestins and Cell Signaling , 2007 .

[49]  Jennifer Williamson,et al.  Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families , 2012, PloS one.

[50]  W. Thies,et al.  2008 Alzheimer’s disease facts and figures , 2008, Alzheimer's & Dementia.

[51]  J L Benovic,et al.  Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). , 1987, Proceedings of the National Academy of Sciences of the United States of America.